Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 23 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. Machine learning for predicting mortality in women diagnosed with breast cancer in the State of Mato Grosso, Brazil using linked population-based cancer registry and mortality data
    Sancho Pedro Xavier, Audêncio Victor, Ana Raquel Ernesto Manuel Gotine +6
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  2. Modifiable determinants of adherence to tyrosine kinase inhibitors in classical myeloproliferative neoplasms: A mixed-methods systematic review protocol
    Fabiana Coelho Inouye, Vivien Teo, Jessie Clarke +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  3. Evolutionary rescue model informs strategies for driving cancer cell populations to extinction
    Amjad Dabi, Joel S. Brown, Robert A. Gatenby +2
    PLOS Computational BiologyPeer-reviewedCC BY 4.0Full textOncologyPLOSPMC
  4. An adapted enhanced social prescribing intervention vs. usual care in the treatment of loneliness in cancer survivors: Study protocol for a feasibility pilot randomized controlled trial
    Brooke Ike, Allison Cole, Brennan Keiser +3
    PLOS OnePeer-reviewedCC BY 4.0Full textClinical trials & evidence synthesisOncologyPLOS
  5. Divergent effects of semaglutide and CRV431 Co-therapy on liver fibrosis and HCC in MASLD mouse model
    Asha Z. Goodman, Winston T. Stauffer, Philippe A. Gallay
    PLOS OnePeer-reviewedCC BY 4.0Full textNutritionOncologyPhysiologyPLOS
  6. Cost and transportation barrier trends related to Affordable Care Act among cancer survivors and atherosclerotic cardiovascular disease patients
    Rabia Bega, Qaidar Alizai, Charalampos M. Charalampous +6
    PLOS Global Public HealthPeer-reviewedCC BY 4.0Full textCardiovascular medicineOncologyPLOS
  7. A first-in-human, phase I/IIa trial of the T cell immunotherapy personalised tumour trained lymphocytes in patients with advanced colorectal cancer: Study protocol
    Ahmed Tarfy, Andrea Salmén, Guro Gafvelin +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  8. Reprogramming M2 macrophages via TLR7/8 agonist-loaded hollow MnO₂ nanovehicles to suppress the progression of liver cancer
    Pei-pei He, Zheng-ju Hou, Han-mei Li +6
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  9. “Even with one Man, but with many women, you can get cervical cancer”: Qualitative exploration of women’s perceptions and experiences of cervical cancer screening in Uganda: A community-based study
    Robert M. Bulamba, Fred Nalugoda, Amanda P. Miller +15
    PLOS Global Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPLOS
  10. Determining essential priorities for future investigation - A national consensus exercise in Interventional Oncology (DEFINE-IO) – An a priori protocol
    Vinson Wai-Shun Chan, Blair Graham, Helen Hoi-Lam Ng +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  11. A T-cell exhaustion-related signature for predicting response to immunotherapy among patients with lung adenocarcinoma
    Chengcheng Yang, Zefeng Wang, Jintao Xie +4
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  12. Targeted dual-responsive nanocapsules for synergistic cisplatin and paclitaxel prodrug delivery in the treatment of lung cancer
    Xinyu Wang, Dan Qin, Chunyu Yao +10
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  13. Social Inequalities, Geographical Accessibility to Care, and Excess Mortality for Patients With Hematological Malignancies in France: Results From French Cancer Registries
    J. Gardy, X. Troussard, M. Maynadié +17
    Hematological OncologyPeer-reviewedLicence not statedFull textOncologyHAL
  14. Temporal dynamics of immune effector cell‐associated haematotoxicity: Linking early and late cytopenias after chimeric antigen receptor T cells
    Malvina Bichon, Roch Houot, Mana Alshehri +3
    British Journal of HaematologyPeer-reviewedCC BY 4.0Full textOncologyHAL
  15. Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm
    Guillaume Cartron, Isabelle Chaillol, Roch Houot +21
    Journal of Hematology and OncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  16. Meroterpenoids Composed of Flavone and Cyclic Sesquiterpene from Syzygium oblanceolatum
    Rintaro Muroda, Nona Koga, Kaede Kawashima +6
    Chemical and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textOncologyJ-STAGE
  17. Adult Pilomyxoid Astrocytoma Mimicking a Craniopharyngioma: An Unusual Suprasellar Presentation
    Sarang Gotecha, Addagada Avinash, Ashish Chugh +1
    Annals of African MedicinePeer-reviewedCC BY-NC-SA 4.0Full textOncologyPMC
  18. Intraoperative or postoperative radiotherapy boost in high-risk breast cancer: a matched-pair analysis
    Gustavo R. Sarria, Cas Dejonckheere, Jorge Fernandez +5
    Strahlentherapie Und OnkologiePeer-reviewedCC BY 4.0Full textOncologyPMC
  19. Implications of Weight-Bearing Locations on Clinical and Survival Patterns in Acral Melanoma
    Noah Yonas, Aileen Y. Chang, Michael Tetzlaff +2
    Journal of the American Academy of DermatologyPeer-reviewedLicence not statedFull textOncologyPMC
  20. The C-reactive protein–albumin–lymphocyte index as a predictor of new-onset atrial fibrillation after ST-segment elevation myocardial infarction: A retrospective cohort study
    Mengchao Jin, Siliang Peng, Kun Liu +3
    The Journal of International Medical ResearchPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  21. Identification of a necroptosis-related lncRNA prognostic signature and the hub RBP HNRNPK in esophageal squamous cell carcinoma
    Shaoyi Zheng, Haoshuai Yang, Wei Liu +4
    The Journal of International Medical ResearchPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  22. Single-Cell Analysis of Non-Functioning Gonadotroph Tumors Identifies Lineage Infidelity and Tumor Growth Programs
    E. Dennis, G. D. Kim, Y. Zhou +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  23. A Patient-Derived Ex Vivo Tissue Model of Cholangiocarcinoma Using Precision-Cut Tissue Slices
    T. M. Gilbert, O. McGreevy, M.-D. Jessel +14
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  24. How optimal control of cellular cost shapes population-level tumor growth dynamics
    P. Shrestha, J. T. George
    bioRxivPreprintCC BYFull textOncologybioRxiv
  25. Deciphering the Network Architecture of APOBEC3-Driven Mutagenesis in HPV-Positive Head and Neck Cancers
    J. D. Lehle, M. Soleimanpour, N. Haghjoo +7
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv